PlainPharmaWatch

CMS Open Payments · Tool

Asahi Intecc USA, Inc. vs BSN Medical Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

BSN Medical Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 9,445, versus 885 for the other company. Its single largest recorded recipient represents 97.2% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Asahi Intecc USA, Inc.
HHI 885 · top recipient 22.6%
Ranked #1,074 of 1,838 companies by HHI
BSN Medical Inc
HHI 9,445 · top recipient 97.2%
Ranked #159 of 1,838 companies by HHI

Payment Overview

Total Payments
$443.1K
% of Industry
0.0%
Transactions
1,313
Avg per Transaction
$337.45
Recipients
1,313
Avg per Recipient
$337.45
Payment Types
5
Top Payment Type
Grant
Company B

BSN Medical Inc

Total Payments
$445.4K
% of Industry
0.0%
Transactions
328
Avg per Transaction
$1.4K
Recipients
328
Avg per Recipient
$1.4K
Payment Types
3
Top Payment Type
Royalty or License

Highlighted values indicate the higher figure for each metric.

Total payments compared

Asahi Intecc USA, Inc. vs BSN Medical Inc - total reported payments in CMS Open Payments PY2024

BSN Medical Inc$445.4KAsahi Intecc USA, Inc.$443.1K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Asahi Intecc USA, Inc.

Grant $225.0K

50.8%

Honoraria $138.2K

31.2%

Food and Beverage $70.5K

15.9%

Travel and Lodging $8.0K

1.8%

Consulting Fee $1.4K

0.3%

BSN Medical Inc

Royalty or License $432.9K

97.2%

Food and Beverage $10.1K

2.3%

Compensation for Services Other Than Consulting $2.5K

0.6%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Asahi Intecc USA, Inc.

  1. 1

    University Of Chicago Hospitals

    $100,000.00 · 1 txns

  2. 2

    University Of Washington Med Ctr

    $60,000.00 · 2 txns

  3. 3

    Massachusetts General Hospital

    $40,000.00 · 3 txns

  4. 4

    Emory University Hospital

    $25,000.00 · 1 txns

  5. 5

    AMEER HASSAN

    $19,411.05 · 6 txns

BSN Medical Inc

  1. 1

    WADE FARROW

    $432,885.05 · 1 txns

  2. 2

    RAMON COLLAZO BIGLES

    $1,238.18 · 5 txns

  3. 3

    ROBERT KLEIN

    $667.50 · 1 txns

  4. 4

    JAMES STILLERMAN

    $585.00 · 1 txns

  5. 5

    MICHAEL WILES

    $176.25 · 4 txns

Summary Comparison

Metric Asahi Intecc USA, Inc. BSN Medical Inc
Total Payments $443.1K $445.4K
% of Industry Total 0.0% 0.0%
Transaction Count 1,313 328
Avg per Transaction $337.45 $1.4K
Recipient Count 1,313 328
Avg per Recipient $337.45 $1.4K
Payment Type Count 5 3
Top Payment Type Grant Royalty or License

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.